Additionally, HaPrP partially mitigated the neuropathologic consequences of prion infection as high dose treated animals showed a trend toward fewer activated astrocytes as revealed by immunohistochemistry for glial fibrillary acidic protein and less severe neuropil spongiosis.
← all excerpts
Potential approaches for heterologous prion protein treatment of prion diseases.
1
—
—